| Revision as of 17:44, 8 April 2013 editChicago1432 (talk | contribs)32 edits please come to the discussion before editing of this page← Previous edit | Revision as of 17:51, 8 April 2013 edit undoChicago1432 (talk | contribs)32 edits replaced to the important referenceNext edit → | ||
| Line 12: | Line 12: | ||
| | url = {{URL|http://www.omicsonline.org/}} | | url = {{URL|http://www.omicsonline.org/}} | ||
| }} | }} | ||
| '''OMICS Publishing Group''' is a publisher of approximately 250 ] journals in a number of academic fields. The company's director is Srinubabu Gedela,<ref name=nyt>Gina Kolata, , ''New York Times'', 8 April 2013</ref> and it has offices in ] (United States), ], and ].<ref name=nature /> It is part of the Hyderabad-based OMICS Group,<ref>{{cite web|url=http://www.omicsonline.org/contact.php |title=OMICS Publishing Group :: Contact |publisher=Omicsonline.org |date= |accessdate=2012-10-03}}</ref> which also has another branch, OMICS Group Conferences, which organizes scientific conferences.<ref>{{cite web|url= | '''OMICS Publishing Group''' is a publisher of approximately 250 ] journals in a number of academic fields. The company's director is Srinubabu Gedela,,,<ref>{{cite web|last=Jagdale |first=Sachin |url=http://pharma.financialexpress.com/sections/market-section/1341-criteria-of-speaker-selection-is-important-to-convey-the-quality-level |title= Speaker selection : Pharma Conferences |publisher=financialexpress.com |date=2012-22-10 |accessdate=2014-01-04}}</ref><ref name=nyt>Gina Kolata, , ''New York Times'', 8 April 2013</ref> and it has offices in ] (United States), ], and ].<ref name=nature /> It is part of the Hyderabad-based OMICS Group,<ref>{{cite web|url=http://www.omicsonline.org/contact.php |title=OMICS Publishing Group :: Contact |publisher=Omicsonline.org |date= |accessdate=2012-10-03}}</ref> which also has another branch, OMICS Group Conferences, which organizes scientific conferences.<ref>{{cite web|url= | ||
| http://www.omicsonline.org/international-scientific-conferences/previousconferences.php|title=Previous OMICS Group Conferences |date= |accessdate=2012-11-20}}</ref> The group started its first open-access journal, the ''Journal of Proteomics & Bioinformatics'', in 2008.<ref>{{cite journal |last=Simpson |first=Richard J. |title=Editorial |journal=Journal of Proteomics & Bioinformatics |year=2008 |month=April |volume=1 |issue=1 |pages=i-ii |url=http://www.omicsonline.org/ArchiveJPB/2008/April/01/JPB1.i.pdf |accessdate=20 November 2012}}</ref> | http://www.omicsonline.org/international-scientific-conferences/previousconferences.php|title=Previous OMICS Group Conferences |date= |accessdate=2012-11-20}}</ref> The group started its first open-access journal, the ''Journal of Proteomics & Bioinformatics'', in 2008.<ref>{{cite journal |last=Simpson |first=Richard J. |title=Editorial |journal=Journal of Proteomics & Bioinformatics |year=2008 |month=April |volume=1 |issue=1 |pages=i-ii |url=http://www.omicsonline.org/ArchiveJPB/2008/April/01/JPB1.i.pdf |accessdate=20 November 2012}}</ref> | ||
Revision as of 17:51, 8 April 2013
 | |
| Parent company | OMICS Group Inc. |
|---|---|
| Status | Active |
| Founded | 2007 (2007) |
| Distribution | Worldwide |
| Publication types | Scientific journals |
| Nonfiction topics | Science |
| Official website | www |
OMICS Publishing Group is a publisher of approximately 250 open access journals in a number of academic fields. The company's director is Srinubabu Gedela,,, and it has offices in Los Angeles (United States), Hyderabad (India), and Henderson (Nevada, United States). It is part of the Hyderabad-based OMICS Group, which also has another branch, OMICS Group Conferences, which organizes scientific conferences. The group started its first open-access journal, the Journal of Proteomics & Bioinformatics, in 2008.
Some observers have described the publisher as "predatory", insofar as authors who have submitted papers have been sent invoices after their manuscripts were accepted for publication despite the lack of a robust peer-review process. One author received an invoice for $2700 after her paper was accepted; this fee was not mentioned in the email message OMICS sent her to solicit a submission. These observations have led critics to assert that the main purpose of the publisher is commercial rather than academic. There is no compromise on quality review policy,” Dr. Gedela wrote in an e-mail to New York Times. “Our team’s hard work and dedicated services to the scientific community will answer all the baseless and defamatory comments that have been made about Omics.
Some academics have been listed for OMICS editorial boards or conferences without their agreement; the company has also been slow to remove the names of editorial board members who requested to terminate their relationship with OMICS activities.
References
- Jagdale, Sachin (2012-22-10). "Speaker selection : Pharma Conferences". financialexpress.com. Retrieved 2014-01-04.
{{cite web}}: Check date values in:|date=(help) - ^ Gina Kolata, "Scientific Articles Accepted (Personal Checks, Too)", New York Times, 8 April 2013
- ^ Declan Butler, "Investigating journals: The dark side of publishing", Nature, 27 March 2013
- "OMICS Publishing Group :: Contact". Omicsonline.org. Retrieved 2012-10-03.
- "Previous OMICS Group Conferences". Retrieved 2012-11-20.
- Simpson, Richard J. (2008). "Editorial" (PDF). Journal of Proteomics & Bioinformatics. 1 (1): i–ii. Retrieved 20 November 2012.
{{cite journal}}: Unknown parameter|month=ignored (help) - Stratford, Michael (2012-03-04). "'Predatory' Online Journals Lure Scholars Who Are Eager to Publish". Chronicle.com. Retrieved 2012-10-02.
- "The Charleston Advisor Update: Predatory Open-Access Scholarly Publishers". Charleston.publisher.ingentaconnect.com. 2010-07-01. Retrieved 2012-10-02.